Status Finished Effective start/end date 1/08/18 → 31/12/24
University of Leuven, Belgium
Antithrombin
Pharmacology, Toxicology and Pharmaceutical Science
100%
Fibrinolytic Agent
Pharmacology, Toxicology and Pharmaceutical Science
50%
Clopidogrel
Pharmacology, Toxicology and Pharmaceutical Science
50%
Antiplatelet
Pharmacology, Toxicology and Pharmaceutical Science
50%
Heart Infarction
Pharmacology, Toxicology and Pharmaceutical Science
50%
Tenecteplase
Pharmacology, Toxicology and Pharmaceutical Science
50%
ST Segment Elevation Myocardial Infarction
Pharmacology, Toxicology and Pharmaceutical Science
50%
Acetylsalicylic Acid
Pharmacology, Toxicology and Pharmaceutical Science
25%